JP2019533639A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533639A5
JP2019533639A5 JP2019512307A JP2019512307A JP2019533639A5 JP 2019533639 A5 JP2019533639 A5 JP 2019533639A5 JP 2019512307 A JP2019512307 A JP 2019512307A JP 2019512307 A JP2019512307 A JP 2019512307A JP 2019533639 A5 JP2019533639 A5 JP 2019533639A5
Authority
JP
Japan
Prior art keywords
compound according
compound
substituted
groups
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019512307A
Other languages
English (en)
Japanese (ja)
Other versions
JP7181857B2 (ja
JP2019533639A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/049768 external-priority patent/WO2018045246A1/en
Publication of JP2019533639A publication Critical patent/JP2019533639A/ja
Publication of JP2019533639A5 publication Critical patent/JP2019533639A5/ja
Application granted granted Critical
Publication of JP7181857B2 publication Critical patent/JP7181857B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019512307A 2016-09-02 2017-08-31 Ｃｘｃｒ３受容体アゴニスト Active JP7181857B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662383202P 2016-09-02 2016-09-02
US62/383,202 2016-09-02
US201762478496P 2017-03-29 2017-03-29
US62/478,496 2017-03-29
PCT/US2017/049768 WO2018045246A1 (en) 2016-09-02 2017-08-31 Cxcr3 receptor agonists

Publications (3)

Publication Number Publication Date
JP2019533639A JP2019533639A (ja) 2019-11-21
JP2019533639A5 true JP2019533639A5 (cg-RX-API-DMAC7.html) 2020-10-01
JP7181857B2 JP7181857B2 (ja) 2022-12-01

Family

ID=59846729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019512307A Active JP7181857B2 (ja) 2016-09-02 2017-08-31 Ｃｘｃｒ３受容体アゴニスト

Country Status (8)

Country Link
US (2) US20190345133A1 (cg-RX-API-DMAC7.html)
EP (1) EP3507275B1 (cg-RX-API-DMAC7.html)
JP (1) JP7181857B2 (cg-RX-API-DMAC7.html)
AU (1) AU2017318674B2 (cg-RX-API-DMAC7.html)
CA (1) CA3034108A1 (cg-RX-API-DMAC7.html)
ES (1) ES2950560T3 (cg-RX-API-DMAC7.html)
MX (1) MX380217B (cg-RX-API-DMAC7.html)
WO (1) WO2018045246A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4103223A4 (en) 2020-02-12 2024-05-29 The Regents of the University of California PLATELET FACTORS AND COGNITIVE IMPROVEMENT
CN111943823A (zh) * 2020-09-16 2020-11-17 安徽工业大学 一种苯菌酮的制备方法
CN116178383B (zh) * 2022-12-26 2025-04-22 南方科技大学 生物碱及三价铁卟啉催化合成生物碱的方法

Similar Documents

Publication Publication Date Title
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2022505987A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2017511360A5 (cg-RX-API-DMAC7.html)
JP2013512903A5 (cg-RX-API-DMAC7.html)
JP2017526726A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2019535723A5 (cg-RX-API-DMAC7.html)
JP2011529918A5 (cg-RX-API-DMAC7.html)
JP2013010792A5 (cg-RX-API-DMAC7.html)
JP2017531619A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
RU2019141734A (ru) Терапевтические соединения и композиции и способы их применения
RU2017112048A (ru) Синергистические комбинации ауристана
JP2015512860A5 (cg-RX-API-DMAC7.html)
JP2019510034A5 (cg-RX-API-DMAC7.html)
JP2016516043A5 (cg-RX-API-DMAC7.html)
JP2014506907A5 (cg-RX-API-DMAC7.html)
JP2011523412A5 (cg-RX-API-DMAC7.html)
JP2017523169A5 (cg-RX-API-DMAC7.html)
JP2014503574A5 (cg-RX-API-DMAC7.html)
JP2017508782A5 (cg-RX-API-DMAC7.html)
UA114521C2 (uk) Солі і тверді форми (s)-3-(4-((4-морфолінометил)-бензил)оксі)-1-оксоізоіндолін-2-іл)-піперидин-2,6-діону і композиції, які їх включають, і способи їхнього застосування